Skip to content

  • about us
  • pipeline
    • CTD
    • SBS-IF
    • CDD
    • NP-300
    • NP-300
  • investors & news
  • clinical trials
    • current Napo Pharmaceutical trials
    • for investigator-initiated trials
  • sustainability & benefit sharing
  • careers
  • about us
  • pipeline
    • CTD
    • SBS-IF
    • CDD
    • NP-300
    • NP-300
  • investors & news
  • clinical trials
    • current Napo Pharmaceutical trials
    • for investigator-initiated trials
  • sustainability & benefit sharing
  • careers

m-chart-21Development2022-08-11T09:09:16-05:00

napo pharmaceuticals logo

Napo Pharmaceuticals, Inc.
200 Pine Street, Suite 400
San Francisco, CA 94104

©2025 Napo Pharmaceuticals, Inc.

MYTESI® CALL CENTER
For product information, adverse event
reports, and product complaint reports,
please contact the Mytesi® Call Center at

(844) 722-8256 or by email at
product.inquiries@napopharma.com
Web Accessibility Feedback Email
Web Accessibility Feedback Form

  • homepage
  • about us
  • pipeline
  • cancer therapy–related diarrhea (CTD)
  • short bowel syndrome with intestinal failure (SBS-IF)
  • congenital diarrheal disorders (CDD)
  • NP-300
  • NP-300
  • investors & news
  • clinical trials
  • sustainability & benefit sharing
  • careers
  • contact us
  • privacy policy
  • cookie policy
  • terms of use
  • comprehensive compliance policy
napo pharmaceuticals logo
  • homepage
  • about us
  • pipeline
  • cancer therapy–related diarrhea (CTD)
  • short bowel syndrome with intestinal failure (SBS-IF)
  • congenital diarrheal disorders (CDD)
  • NP-300
  • NP-300
  • investors & news
  • clinical trials
  • sustainability & benefit sharing
  • careers
  • contact us
  • privacy policy
  • cookie policy
  • terms of use
  • comprehensive compliance policy

MYTESI® CALL CENTER
For product information, adverse event
reports, and product complaint reports,
please contact the Mytesi® Call Center at

(844) 722-8256 or by email at
product.inquiries@napopharma1.wpenginepowered.com
Web Accessibility Feedback Email
Web Accessibility Feedback Form

Napo Pharmaceuticals, Inc.
200 Pine Street, Suite 400
San Francisco, CA 94104

©2023 Napo Pharmaceuticals Inc.

Page load link

You are being directed to an external site.

Continue
Go to Top